Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA)

General Info

Geography

Denmark (DNK)

Finland (FIN)

Ireland (IRL)

Norway (NOR)

Sweden (SWE)

United Kingdom (GBR)

View all

Time period covered

January, 1998 - December, 2002

Data type

Scientific literature

Keywords

Cardiovascular and circulatory diseases, Cholesterol, Heart failure, Ischemic heart disease, Stroke

Citation

Authors

Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT investigators

Journal

Lancet

Pages

1149-58

Publication year

2003

Suggested citation

Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA). Lancet. 2003; 361(9364): 1149-58.